XT
COCP icon

XTX Topco’s Cocrystal Pharma COCP Stock Holding History

XTX Topco’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.8K Sell
29,342
-6,689
-19% -$8.23K ﹤0.01% 3822
2026
Q1 		$36.4K Buy
36,031
+20,890
+138% +$21.6K ﹤0.01% 3410
2025
Q4 		$14.8K Buy
+15,141
New +$16K ﹤0.01% 3123

Other funds holding COCP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco's COCP Position: Q2 2026 in Review

XTX Topco reduced its Cocrystal Pharma (COCP) stake by 19% in Q2 2026, selling an estimated $8.23K and leaving 29,342 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3822.

XTX Topco first reported a position in COCP in Q4 2025 and has held it in 3 quarters since. The position peaked at $36.4K in Q1 2026. 27 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

  • XTX Topco held 29,342 shares of Cocrystal Pharma worth $30.8K as of Q2 2026.
  • XTX Topco sold 6,689 Cocrystal Pharma shares in Q2 2026, an estimated $8.23K.
  • Cocrystal Pharma made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3822 holding.
  • XTX Topco first reported a position in Cocrystal Pharma in Q4 2025 and has held it in 3 quarters since.
  • XTX Topco's Cocrystal Pharma position peaked at $36.4K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.